HEPARIN MODULATES THE 99-LOOP OF FACTOR IXa: EFFECTS ON REACTIVITY WITH ISOLATED KUNITZ-TYPE INHIBITOR DOMAINS

Por Neuenschwander, Pierre F., Williamson, Stephen R., Nalian, Armen, Baker-Deadmond, Kimberly J.
Publicado em 2006

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

Por Williamson, Stephen K., Moon, James, Huang, Chao H., Guaglianone, Perry P., LeBlanc, Michael, Wolf, Gregory T., Urba, Susan G.
Publicado em 2010

Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S...

Por Arnold, Susanne M., Moon, James, Williamson, Stephen K., Atkins, James N., Ou, Sai-Hong I., LeBlanc, Michael, Urba, Susan G.
Publicado em 2009

Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: A study based on SWOG protocol S0420

Por MEHTA, SMITA, MOON, JAMES, HASHMI, MEHMOOD, LEBLANC, MICHAEL, HUANG, CHAO HUI, RINEHART, ELIZABETH, WOLF, GREGORY T., URBA, SUSAN G., BANERJEE, SUSHANTA K., WILLIAMSON, STEPHEN
Publicado em 2013

Leiomyosarcoma of the inferior vena cava: a case report and review of the literature

Por Reddy, Venkataprasanth P, VanVeldhuizen, Peter J, Muehlebach, Gregory F, Dusing, Reginald W, Birkbeck, James P, Williamson, Stephen K, Krishnan, Leela, Meyers, David G
Publicado em 2010

SWOG 0709: Randomized Phase II Trial of Erlotinib vs. Erlotinib plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as...

Por Lara, Primo N., Moon, James, Hesketh, Paul J., Redman, Mary W., Williamson, Stephen K., Akerley, Wallace L., Hirsch, Fred R., Mack, Philip C., Gandara, David R.
Publicado no J Thorac Oncol (2015)

Phase II Study of Tirapazamine, Cisplatin, and Etoposide and Concurrent Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer: SWOG 0222

Por Le, Quynh-Thu X., Moon, James, Redman, Mary, Williamson, Stephen K., Lara, Primo N., Goldberg, Zelanna, Gaspar, Laurie E., Crowley, John J., Moore, Dennis F., Gandara, David R.
Publicado em 2009

Chemotherapy Outcomes by Histologic Subtypes of Non-Small cell Lung Cancer: Analysis of the Southwest Oncology Group Database for Antimicrotubule-Platinum Therapy

Por Kelly, Karen, Chansky, Kari, Mack, Philip C., Lara, Primo N., Hirsch, Fred R., Franklin, Wilbur A, Wozniak, Antoinette J., Edelman, Martin J., Williamson, Stephen K., Gandara, David R
Publicado em 2013

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741

Por Sanoff, Hanna K., Sargent, Daniel J., Campbell, Megan E., Morton, Roscoe F., Fuchs, Charles S., Ramanathan, Ramesh K., Williamson, Stephen K., Findlay, Brian P., Pitot, Henry C., Goldberg, Richard M.
Publicado em 2008

Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003

Por Mack, Philip C., Redman, Mary W., Chansky, Kari, Williamson, Stephen K., Farneth, Nichole C., Lara, Primo N., Franklin, Wilbur A., Le, Quynh-Thu, Crowley, John J., Gandara, David R.
Publicado em 2008

High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study

Por Polireddy, Kishore, Dong, Ruochen, Reed, Gregory, Yu, Jun, Chen, Ping, Williamson, Stephen, Violet, Pierre-Christian, Pessetto, Ziyan, Godwin, Andrew K., Fan, Fang, Levine, Mark, Drisko, Jeanne A., Chen, Qi
Publicado no Sci Rep (2017)

A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma

Por Abou‐Alfa, Ghassan K., Miksad, Rebecca A., Tejani, Mohamedtaki A., Williamson, Stephen, Gutierrez, Martin E., Olowokure, Olugbenga O., Sharma, Manish R., El Dika, Imane, Sherman, Matthew L., Pandya, Shuchi S.
Publicado no Oncologist (2018)

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

Por Huang, Chao H., Williamson, Stephen K., Neupane, Prakash, Taylor, Sarah A., Allen, Ace, Smart, Nora J., Uypeckcuat, Adelina M., Spencer, Sarah, Wick, Jo, Smith, Holly, Van Veldhuizen, Peter J., Kelly, Karen
Publicado no Front Oncol (2016)

A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer

Por Huang, Chao H., Wick, Jo A., Sittampalam, Gurusingham Sitta, Nirmalanandhan, Victor Sanjit, Ganti, Apar Kishor, Neupane, Prakash C., Williamson, Stephen K., Godwin, Andrew K., Schmitt, Sarah, Smart, Nora J., Spencer, Sarah, Van Veldhuizen, Peter J.
Publicado em 2014

RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC)

Por Ezzeldin, Mohamad, Borrego-Diaz, Emma, Taha, Mohammad, Esfandyari, Tuba, Wise, Amanda L., Peng, Warner, Rouyanian, Alex, Asvadi Kermani, Atabak, Soleimani, Mina, Patrad, Elham, Lialyte, Kristina, Wang, Kun, Williamson, Stephen, Abdulkarim, Bashar, Olyaee, Mojtaba, Farassati, Faris
Publicado no Mol Oncol (2014)

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

Por McLeod, Howard L., Sargent, Daniel J., Marsh, Sharon, Green, Erin M., King, Cristi R., Fuchs, Charles S., Ramanathan, Ramesh K., Williamson, Stephen K., Findlay, Brian P., Thibodeau, Stephen N., Grothey, Axel, Morton, Roscoe F., Goldberg, Richard M.
Publicado em 2010

Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics

Por Gandara, David R., Kawaguchi, Tomoya, Crowley, John, Moon, James, Furuse, Kiyoyuki, Kawahara, Masaaki, Teramukai, Satoshi, Ohe, Yuichiro, Kubota, Kaoru, Williamson, Stephen K., Gautschi, Oliver, Lenz, Heinz Josef, McLeod, Howard L., Lara, Primo N., Coltman, Charles Arthur, Fukuoka, Masahiro, Saijo, Nagahiro, Fukushima, Masanori, Mack, Philip C.
Publicado em 2009

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax(®)) in patients with peritoneal malignancies

Por Williamson, Stephen K., Johnson, Gary A., Maulhardt, Holly A., Moore, Kathleen M., McMeekin, D. S., Schulz, Thomas K., Reed, Gregory A., Roby, Katherine F., Mackay, Christine B., Smith, Holly J., Weir, Scott J., Wick, Jo A., Markman, Maurie, diZerega, Gere S., Baltezor, Michael J., Espinosa, Jahna, Decedue, Charles J.
Publicado no Cancer Chemother Pharmacol (2015)